Welcome to LookChem.com Sign In|Join Free
  • or
2,3-Dioxoindoline-7-carboxylic Acid is a specialized organic compound belonging to the indolines and indoles family. It has the chemical formula C9H5NO4, which signifies the presence of carbon, hydrogen, nitrogen, and oxygen atoms. 2,3-DIOXOINDOLINE-7-CARBOXYLIC ACID is characterized by an indoline backbone with a ketone group at the 2nd and 3rd positions and a carboxylic acid group at the 7th position. The physical properties such as solubility, melting point, flash point, and toxicity may vary under different conditions. It has potential applications in various fields, including medicinal chemistry, synthetic chemistry, material science, and the pharmaceutical industry. Due to its nature, it is essential to handle this chemical with care and follow appropriate safety measures.

25128-35-2

Post Buying Request

25128-35-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

25128-35-2 Usage

Uses

Used in Medicinal Chemistry:
2,3-Dioxoindoline-7-carboxylic Acid is used as a building block for the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a valuable component in the development of new drugs with specific therapeutic properties.
Used in Synthetic Chemistry:
In synthetic chemistry, 2,3-Dioxoindoline-7-carboxylic Acid serves as a versatile intermediate for the preparation of a wide range of organic compounds. Its reactivity and functional groups allow for various chemical reactions, enabling the synthesis of complex molecules with desired properties.
Used in Material Science:
2,3-Dioxoindoline-7-carboxylic Acid can be utilized in the development of novel materials with specific properties. Its incorporation into polymers or other materials can lead to the creation of materials with improved characteristics, such as enhanced stability, reactivity, or selectivity.
Used in Pharmaceutical Industry:
2,3-Dioxoindoline-7-carboxylic Acid is used as an active pharmaceutical ingredient (API) for the development of new drugs. Its unique structure and functional groups can be exploited to design and synthesize compounds with specific therapeutic effects, potentially leading to the discovery of new treatments for various diseases and conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 25128-35-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,5,1,2 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 25128-35:
(7*2)+(6*5)+(5*1)+(4*2)+(3*8)+(2*3)+(1*5)=92
92 % 10 = 2
So 25128-35-2 is a valid CAS Registry Number.
InChI:InChI=1/C9H5NO4/c11-7-4-2-1-3-5(9(13)14)6(4)10-8(7)12/h1-3H,(H,13,14)(H,10,11,12)

25128-35-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3-dioxo-1H-indole-7-carboxylic acid

1.2 Other means of identification

Product number -
Other names 2,3-dioxoindoline-7-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:25128-35-2 SDS

25128-35-2Relevant academic research and scientific papers

Bisintercalating Threading Diacridines: Relationships between DNA Binding, Cytotoxicity, and Cell Cycle Arrest

Wakelin, Laurence P. G.,Bu, Xianyong,Eleftheriou, Alexandra,Parmar, Alpesh,Hayek, Charbel,Stewart, Bernard W.

, p. 5790 - 5802 (2003)

We have synthesized a series of bis(9-aminoacridine-4-carboxamides) linked via the 9-position with neutral flexible alkyl chains, charged flexible polyamine chains, and a semirigid charged piperazine-containing chain. The carboxamide side chains comprise N,N-dimethylaminoethyl and ethylmorpholino groups. The compounds are designed to bisintercalate into DNA by a threading mode, in which the side chains are intended to form hydrogen-bonding contacts with the O6/N7 atoms of guanine in the major groove, and the linkers are intended to lie in the minor groove. By this means, we anticipate that they will dissociate slowly from DNA, and be cytotoxic as a consequence of template inhibition of transcription. The dimers remove and reverse the supercoiling of closed circular DNA with helix unwinding angles ranging from 26° to 46°, confirming bifunctional intercalation in all cases, and the DNA complexes of representative members dissociate many orders of magnitude more slowly than simple aminoacridines. Cytotoxicity for human leukemic CCRF-CEM cells was determined, the most active agents having IC50 values of 35-50 nM in a range extending over 20-fold, with neither the dimethylaminoethyl nor the ethylmorpholino series being intrinsically more toxic. In common with established transcription inhibitors, the morpholino series, with one exception, have no effect on cell cycle distribution in randomly dividing CCRF-CEM populations. By contrast, the dimethylaminoethyl series, with two exceptions, cause G2/M arrest in the manner of topoisomerase poisons, consistent with possible involvement of topoisomerases in their mode of action. Thus, the cellular response to these bisintercalating threading agents is complex and appears to be determined by both their side chain and linker structures. There are no simple relationships between structure, cytotoxicity, and cell cycle arrest, and the origins of this complexity are unclear given that the compounds bind to DNA by a common mechanism.

Synthesis and antitumor properties of N-[2- (dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: A new class of putative topoisomerase inhibitors

Deady, Leslie W.,Kaye, Anthony J.,Finlay, Graeme J.,Baguley, Bruce C.,Denny, William A.

, p. 2040 - 2046 (1997)

A series of tetracyclic quinoline- and quinoxalinecarboxamides were prepared, and their cytotoxicities were evaluated in a series of murine human tumor cell lines. Most of the quinoline derivatives were prepared by an adaptation of the Pfitzinger synthesis, followed by thermal decarboxylation and coupling with N,N-dimethylethylenediamine via a mixed anhydride method using isobutyl chloroformate. The quinoline analogues showed cytotoxicities broadly similar to those of the known tricyclic acridine-4-carboxamide mixed topoI/II inhibitor DACA, with thieno and indeno analogues being the most active. They showed little decrease in potencies against the Jurkat human leukemia topo II-resistant lines JL(A) and JL(C), suggesting their cytotoxicity does not result primarily from inhibition of topo II. The quinoxaline analogues had more varied IC50 values, being on average less cytotoxic than the quinoline derivatives, but appeared to have a similar mode of action. Overall, this new class of compounds appear to be mixed topo I/II inhibitors, up to 3-fold more cytotoxic than DACA in the human leukemia cell lines studied, with in vivo activity in colon 38 comparable to that of DACA and doxorubicin.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 25128-35-2